Office of Generic Drugs

The Office of Generic Drugs (OGD) is a division within the U.S. Food and Drug Administration (FDA) responsible for evaluating and approving generic versions of brand-name medications. Their goal is to ensure these generics are safe, effective, and of high quality, matching the original drugs in strength and performance. By streamlining approval processes, the OGD helps make essential medications more affordable and accessible for patients, while maintaining strict regulatory standards. Essentially, they oversee the safe introduction of cost-effective medication options that provide similar benefits to those of brand-name drugs.